Effect of melphalan and hyperthermia on cell cycle progression and cyclin B1 expression in human melanoma cells
- 1 November 1995
- journal article
- Published by Wiley in Cell Proliferation
- Vol. 28 (11) , 617-630
- https://doi.org/10.1111/j.1365-2184.1995.tb00049.x
Abstract
We have investigated the effect of mild hyperthermia (42°C) on the cytotoxic activity of a 1 h melphalan exposure in human melanoma cell lines. Hyperthermia did not affect cell growth of any culture, but it increased, to a different extent, melphalan cytotoxicity in all cell lines, with a reduction in the IC50 of 1.7 to 2.6‐fold. Flow cytometric analysis showed that in normal temperature conditions melphalan caused S phase cell accumulation, which was evident only at 24 h in JR8, M14 and 2/21 cell lines and was still persistent at 72 h in 2/60 cells. Moreover, in all cell lines, the delay in S phase was paralleled, or followed, by an accumulation of cells in G2+ M, which was transient in JR8 and M14 cells and persisted until 72 h in 2/21 and 2/60 melanoma clones. Hyperthermia caused a stabilization and prolongation of melphalan induced G2+ M accumulation in JR8 and M14 cells. Conversely, in 2/21 and 2/60 clones, cell cycle perturbations induced by the drug were similar under normothermic or hyperthermic conditions. Specifically, in JR8, for which the maximum enhancement by hyperthermia on melphalan cytotoxicity was observed, cell accumulation in G2+ M was still present 120 h after treatment. The accumulation was accompanied by an inhibition in the G2 ‐ M transition, as demonstrated by the significant reduction in the mitotic index of cells exposed to combined treatment compared to controls. Moreover, a bivariate distribution of cells stained for DNA and cyclin B1 showed that, following melphalan and hyperthermia treatment, the fraction of cyclin B1‐expressing cells paralleled the fraction of G2+ M phase cells, thus indicating that the inability of cells to enter mitosis was not ascribable to a reduction of cyclin B1 expression. On the whole, our results indicate that hyperthermia can stabilize the G2 accumulation induced by melphalan in human melanoma cells. Such a stabilization could contribute to the enhancement of melphalan cytotoxicity by heat, even though a strict correlation was not observed between the magnitude and persistence of the cell cycle perturbations and the extent of melphalan activity.Keywords
This publication has 29 references indexed in Scilit:
- The Protein Kinase C Inhibitor Ilmofosine (BM 41 440) Arrests Cells in G2 Phase and Suppresses CDC2 Kinase Activation Through a Mechanism Different from That of DNA Damaging AgentsBiochemical and Biophysical Research Communications, 1994
- Effect of hyperthermia on the formation and removal of DNA interstrand cross-links induced by melphalan in primary cultures of human malignant melanomaInternational Journal of Hyperthermia, 1992
- Animal Cell Cycles and Their ControlAnnual Review of Biochemistry, 1992
- Universal control mechanism regulating onset of M-phaseNature, 1990
- Seven years experience with hyperthermic perfusions in extracorporeal circulation for melanoma of the extremitiesJournal of Surgical Oncology, 1989
- Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanomaThe International Journal of Cell Cloning, 1989
- Effects of cytostatic drugs and 40.5°C hyperthermia on human clonogenic tumor cellsEuropean Journal of Cancer and Clinical Oncology, 1985
- Strand break repair, DNA polymerase activity and heat radiosensitization in thermotolerant cellsInternational Journal of Hyperthermia, 1985
- Cell cycle stage-dependent induction of G2 phase arrest by different antitumor agentsPublished by Elsevier ,1978